Pinnacle Associates LTD Esperion Therapeutics, Inc. Transaction History

Pinnacle Associates LTD

  • $6.3 Billion
  • Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Pinnacle Associates LTD holds 283,255 shares of ESPR stock, worth $682,644. This represents 0.01% of its overall portfolio holdings.

Number of Shares
283,255
Previous 281,299 0.7%
Holding current value
$682,644
Previous $624,000 25.16%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
BUY
$1.61 - $2.73 $3,149 - $5,339
1,956 Added 0.7%
283,255 $467,000
Q2 2024

Jul 30, 2024
SELL
$1.84 - $3.24 $7,185 - $12,652
-3,905 Reduced 1.37%
281,299 $624,000
Q1 2024

Apr 26, 2024
BUY
$2.02 - $3.02 $3,936 - $5,885
1,949 Added 0.69%
285,204 $764,000
Q4 2023

Jan 19, 2024
SELL
$0.73 - $3.08 $4,283 - $18,073
-5,868 Reduced 2.03%
283,255 $846,000
Q3 2023

Oct 23, 2023
BUY
$0.96 - $1.79 $37,713 - $70,320
39,285 Added 15.72%
289,123 $283,000
Q2 2023

Jul 26, 2023
BUY
$1.2 - $1.76 $3,870 - $5,676
3,225 Added 1.31%
249,838 $347,000
Q1 2023

May 04, 2023
BUY
$1.46 - $7.3 $11,471 - $57,356
7,857 Added 3.29%
246,613 $392,000
Q4 2022

Jan 31, 2023
SELL
$5.09 - $8.5 $27,740 - $46,325
-5,450 Reduced 2.23%
238,756 $1.49 Million
Q4 2022

Jan 25, 2023
BUY
$5.09 - $8.5 $8,093 - $13,515
1,590 Added 0.66%
244,206 $0
Q3 2022

Oct 31, 2022
SELL
$5.45 - $8.13 $79,668 - $118,844
-14,618 Reduced 5.68%
242,616 $1.63 Million
Q2 2022

Aug 02, 2022
SELL
$4.77 - $6.67 $12,158 - $17,001
-2,549 Reduced 0.98%
257,234 $1.64 Million
Q1 2022

May 05, 2022
BUY
$3.34 - $5.56 $13,293 - $22,128
3,980 Added 1.56%
259,783 $1.21 Million
Q4 2021

Feb 02, 2022
SELL
$4.81 - $11.92 $24,800 - $61,459
-5,156 Reduced 1.98%
255,803 $1.28 Million
Q3 2021

Oct 19, 2021
SELL
$11.34 - $21.37 $116,178 - $218,935
-10,245 Reduced 3.78%
260,959 $3.15 Million
Q2 2021

Aug 02, 2021
BUY
$19.4 - $28.71 $81,344 - $120,381
4,193 Added 1.57%
271,204 $5.74 Million
Q1 2021

May 12, 2021
SELL
$25.12 - $36.89 $695,447 - $1.02 Million
-27,685 Reduced 9.39%
267,011 $7.49 Million
Q4 2020

Jan 26, 2021
BUY
$24.2 - $35.76 $924,754 - $1.37 Million
38,213 Added 14.9%
294,696 $7.66 Million
Q3 2020

Oct 23, 2020
SELL
$31.18 - $52.71 $349,216 - $590,352
-11,200 Reduced 4.18%
256,483 $9.53 Million
Q2 2020

Aug 14, 2020
SELL
$30.04 - $51.31 $54,973 - $93,897
-1,830 Reduced 0.68%
267,683 $13.7 Million
Q1 2020

May 13, 2020
SELL
$27.44 - $73.84 $1.27 Million - $3.42 Million
-46,376 Reduced 14.68%
269,513 $8.5 Million
Q4 2019

Feb 03, 2020
BUY
$35.4 - $59.82 $2.57 Million - $4.34 Million
72,560 Added 29.82%
315,889 $18.8 Million
Q3 2019

Nov 08, 2019
BUY
$34.47 - $47.53 $1.92 Million - $2.65 Million
55,780 Added 29.74%
243,329 $8.92 Million
Q2 2019

Aug 05, 2019
BUY
$40.1 - $52.33 $289,722 - $378,084
7,225 Added 4.01%
187,549 $8.73 Million
Q1 2019

May 10, 2019
SELL
$40.11 - $53.57 $134,569 - $179,727
-3,355 Reduced 1.83%
180,324 $7.24 Million
Q4 2018

Feb 05, 2019
SELL
$36.99 - $59.11 $311,270 - $497,410
-8,415 Reduced 4.38%
183,679 $8.45 Million
Q3 2018

Nov 13, 2018
SELL
$40.74 - $51.41 $1.3 Million - $1.64 Million
-31,977 Reduced 14.27%
192,094 $8.52 Million
Q2 2018

Aug 08, 2018
SELL
$36.2 - $76.4 $14.8 Million - $31.2 Million
-408,060 Reduced 64.55%
224,071 $8.78 Million
Q1 2018

May 11, 2018
SELL
$65.94 - $80.76 $1.82 Million - $2.23 Million
-27,672 Reduced 4.19%
632,131 $45.7 Million
Q4 2017

Feb 12, 2018
SELL
$43.47 - $67.43 $2.52 Million - $3.91 Million
-58,010 Reduced 8.08%
659,803 $43.4 Million
Q3 2017

Nov 13, 2017
SELL
$43.8 - $52.77 $728,832 - $878,092
-16,640 Reduced 2.27%
717,813 $36 Million
Q2 2017

Aug 09, 2017
BUY
N/A
734,453
734,453 $34 Million

Others Institutions Holding ESPR

# of Institutions
208
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $160M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email